What is the prevalence of medicine resistance in Oncology?

What is the prevalence of medicine resistance in Oncology?

Resistance has been featured as a major factor known for affecting the treatment of cancer in various individuals. It is known noted when cancer cells contain molecular changes that make them insensitive to different drugs before treatment begins (Abida et al., 2019). Hence, it is important to understand the prevalence of medicine resistance in oncology to provide the required medications for cancer patients.